<?xml version="1.0" encoding="UTF-8"?>
<p id="p0115">RNA polymerase unit (nsp12) is the promising target to develop viral inhibitors and the promising drug remdesivir, which has entered into clinical trials now for the treatment of COVID-19, also inhibits the activity of RdRp.</p>
